EP Patent

EP0259781A2 — Method for selectively increasing the ratio of single major components of antibiotic A 40926 complex

Assigned to Vicuron Pharmaceuticals LLC · Expires 1988-03-16 · 38y expired

What this patent protects

The present invention is directed to a method for selectively enhancing the production of factors A, and/or B₀ of antibiotic A 40926 either to isolate these single components in better yields or to enrich the complex in one or both the above components, which comprises adding an …

USPTO Abstract

The present invention is directed to a method for selectively enhancing the production of factors A, and/or B₀ of antibiotic A 40926 either to isolate these single components in better yields or to enrich the complex in one or both the above components, which comprises adding an appropriate precursor of the desired antibiotic factor to an A 40926 producing culture during fermentation.

Drugs covered by this patent

Patent Metadata

Patent number
EP0259781A2
Jurisdiction
EP
Classification
Expires
1988-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Vicuron Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.